![]() |
市場調查報告書
商品編碼
2075051
低溫運輸運輸市場預測至2034年-全球分析(按運輸方式、溫度範圍、車輛類型、技術、服務類型、最終用戶和地區分類)Cold Chain Transportation Market Forecasts to 2034 - Global Analysis By Transportation Mode, Temperature Range, Vehicle Type, Technology, Service Type, End User and By Geography |
||||||
根據 Stratistics MRC 的數據,預計到 2026 年,全球低溫運輸運輸市場規模將達到 172 億美元,到 2034 年將達到 389 億美元,預測期內複合年成長率為 10.7%。
低溫運輸運輸是指在生鮮產品(例如生鮮食品、冷凍食品、乳製品、藥品、疫苗和生物製藥)從原產地到最終目的地的整個運輸過程中,保持溫度控制的物流網路。這包括冷藏卡車、鐵路貨櫃、航空貨運冷藏室和冷藏運輸貨櫃,並由持續的溫度監控、物聯網追蹤和合規文件管理系統提供支援。
藥品和疫苗分銷需求的激增,擴大了對低溫運輸的需求。
隨著全球製藥業不斷拓展其生物製藥產品線,涵蓋mRNA疫苗、單株抗體以及細胞和基因療法,維持產品療效需要在整個分銷鏈中實施嚴格的溫控運輸。新興市場生物製藥產量的不斷成長催生了新的分銷管道,而這些管道對低溫運輸協調提出了更高的要求。各大市場正在加強藥品良好分銷規範(GDP)的實施,強制要求增加溫度監控和儲存歷史記錄,這正在推動先進的物聯網低溫運輸運輸解決方案的應用。
需要高能耗的營運和大量的基礎設施投資。
冷藏運輸比常溫運輸消耗更多燃料,柴油動力冷凍裝置會使車輛運作成本比標準商用車增加20%至30%。冷藏運輸設備的購置成本,包括保溫拖車車身、低溫系統和遠端資訊處理監控硬體,遠超過傳統貨運資產。始發地、中轉地和目的地所需的冷藏倉庫需要數百萬美元的基礎設施投資,且投資回收期很長。在電力基礎設施不穩定的新興市場,從裝車到中途停靠再到最後一公里配送,整個低溫運輸保持溫度穩定是一項挑戰,這會導致營運可靠性問題,增加食品變質的風險和保險成本。
不斷擴大的有組織的零售和電子商務食品市場需要最後一公里冷藏配送。
線上生鮮購物和食材自煮包配送服務的快速成長,對連接都市區履約中心和住宅消費者的溫控末端物流能力提出了前所未有的需求。包括微型倉配配送車和智慧溫度監控平台在內的都市區低溫運輸基礎設施,正吸引生鮮零售商、食品科技公司和物流供應商的大量投資。隨著消費者對冷藏食品配送的品質和便利性的期望不斷提高,在全球人口密集的城市市場,優質末端低溫運輸服務的經濟效益正變得越來越現實。
食品安全監管合規的複雜性以及相關的法律責任風險。
低溫運輸運輸商面臨日益嚴格且地理分散的監管環境,這些監管要求他們報告溫度偏差、承擔產品召回責任,並對因變質造成的損失承擔責任。食品安全法規,例如美國FDA《食品安全現代化法案》中的《衛生運輸規則》,對溫度監控、文件記錄和培訓提出了具體要求,增加了運輸商的營運成本。跨境低溫運輸運輸需要遵守各國特定的食品和藥品進口法規,而海關檢查的延誤會對時效性要求嚴格的易腐貨物造成溫度敏感型風險。
新冠疫情期間,全球數十億劑疫苗的分發需要超低溫或冷藏,這引發了對低溫運輸運輸前所未有的需求。這一歷史性的需求激增暴露了全球低溫運輸基礎設施的嚴重產能瓶頸,促使公共衛生機構和私人物流營運商緊急投資於冷藏車、冷庫設施和溫度監控技術。疫情後,線上生鮮配送、食材自煮包和藥品直接送達消費者的迅速普及,從根本上增加了對低溫運輸運輸的需求,使其市場規模遠超疫情前水準。這為該行業的基礎設施投資樹立了永久性的高標準。
在預測期內,道路運輸領域預計將佔據最大佔有率。
在預測期內,陸路運輸預計將佔據最大的市場佔有率。這反映了陸路運輸在最後一公里低溫運輸配送中的關鍵作用,其服務對象包括零售配銷中心、超級市場、醫院、藥局和住宅使用者。在所有主要市場,冷藏卡車和貨車主導國內溫控貨運,能夠提供鐵路、航空或海運無法實現的靈活路線和門到門服務,滿足最後一公里配送的需求。
預計在預測期內,航空運輸領域將呈現最高的複合年成長率。
在預測期內,航空貨運領域預計將呈現最高的成長率,這主要得益於對時間要求嚴格的低溫運輸貨物類別(例如新鮮魚貝類、進口農產品、鮮切花和生物製藥)的擴張,這些貨物需要快速運輸以保持其品質和療效。在製藥業,跨境分銷生物製藥、臨床試驗材料和特藥越來越依賴航空貨運,創造了豐厚的低溫運輸航空貨運收入。溫控貨櫃、特製客機貨艙和專用貨機的配置正在不斷提升製藥低溫運輸的效率。
在預測期內,北美預計將保持最大的市場佔有率,這得益於其高度發達的冷藏物流基礎設施、廣泛的國內食品分銷網路以及對溫度控制要求嚴格的大規模藥品分銷行業。美國擁有密集的第三方冷藏物流供應商網路,為食品生產商、食品零售商和製藥公司提供覆蓋全美的溫控配送服務。
在預測期內,亞太地區預計將呈現最高的複合年成長率,這主要得益於有組織的食品零售業的快速擴張、藥品分銷網路的成長以及中國、印度和東南亞各國政府的基礎設施投資計劃。在中國,透過私部門投資和政府政策支持,低溫運輸發展正以前所未有的速度推進,推動農業供應鏈現代化,從而減少食物廢棄物,提高農村到城市的配送效率。
According to Stratistics MRC, the Global Cold Chain Transportation Market is accounted for $17.2 billion in 2026 and is expected to reach $38.9 billion by 2034, growing at a CAGR of 10.7% during the forecast period. Cold Chain Transportation refers to the logistics network that maintains temperature-controlled conditions throughout the movement of perishable goods including fresh produce, frozen foods, dairy products, pharmaceuticals, vaccines, and biologic materials from point of origin to final destination. It encompasses refrigerated road vehicles, rail containers, air freight cold compartments, and sea reefer containers, supported by continuous temperature monitoring, IoT tracking, and compliance documentation systems.
Surging pharmaceutical and vaccine distribution requirements amplifying cold chain demand
The global pharmaceutical sector's expanding biologics pipeline, including mRNA vaccines, monoclonal antibodies, and cell and gene therapies, requires stringent temperature-controlled transportation across the entire distribution chain to preserve product efficacy. Growing biopharmaceutical manufacturing in emerging markets is generating new distribution corridors requiring cold chain connectivity. Regulatory tightening of pharmaceutical Good Distribution Practice guidelines across major markets is mandating enhanced temperature monitoring and chain-of-custody documentation, driving adoption of advanced IoT-enabled cold chain transport solutions.
Energy-intensive operations and high infrastructure investment requirements
Refrigerated transportation consumes significantly more fuel than ambient freight operations, with diesel-powered refrigeration units adding 20-30% to vehicle operating costs compared to standard commercial vehicles. The capital cost of refrigerated transport equipment, including insulated trailer bodies, cryogenic systems, and telematics monitoring hardware, substantially exceeds that of conventional freight assets. Cold storage facilities required at origin, transit, and destination points represent multi-million-dollar infrastructure investments with long payback periods. In emerging markets with unreliable power infrastructure, maintaining consistent cold chain temperatures during vehicle loading, transit stops, and last-mile delivery presents operational reliability challenges that increase spoilage risk and insurance costs.
Expanding organized retail and e-commerce grocery demanding last-mile cold delivery
The rapid growth of online grocery shopping and meal kit delivery services is creating unprecedented demand for temperature-controlled last-mile logistics capabilities connecting urban fulfillment centers with residential consumers. Urban cold chain infrastructure, including micro-fulfillment hubs, electric refrigerated delivery vehicles, and smart temperature monitoring platforms, is attracting substantial investment from grocery retailers, food tech companies, and logistics operators. As consumer expectations for cold food quality and delivery convenience continue rising, the economics of premium last-mile cold chain services are becoming increasingly viable across dense urban markets globally.
Regulatory compliance complexity and food safety liability exposure
Cold chain transportation operators face an increasingly stringent and geographically fragmented regulatory landscape governing temperature excursion reporting, product recall responsibilities, and carrier liability for spoilage losses. Food safety legislation such as the U.S. FDA Food Safety Modernization Act's Sanitary Transportation Rule imposes specific temperature monitoring, documentation, and training requirements that increase operational overhead for transportation providers. Cross-border cold chain shipments must navigate diverse national food and pharmaceutical import regulations, with inspection delays at customs creating temperature risk for time-sensitive perishable cargoes.
The COVID-19 pandemic generated unprecedented demand for cold chain transportation through the global distribution of billions of vaccine doses requiring ultra-cold or refrigerated handling. This historic demand surge exposed significant capacity constraints in cold chain infrastructure worldwide, catalyzing emergency investments in refrigerated vehicle fleets, cold storage facilities, and temperature monitoring technologies by both public health agencies and private logistics operators. Post-pandemic, the accelerated adoption of online grocery, meal kits, and direct-to-consumer pharmaceutical delivery has created structurally elevated demand for cold chain transportation that substantially exceeds pre-pandemic market volumes, establishing a permanently higher baseline for infrastructure investment across the sector.
The Road Transportation segment is expected to be the largest during the forecast period
The Road Transportation segment is expected to account for the largest market share during the forecast period, reflecting its indispensable role in last-mile cold chain delivery to retail distribution centers, supermarkets, hospitals, pharmacies, and residential consumers. Refrigerated trucks and vans constitute the dominant mode for domestic temperature-controlled freight across all major markets, offering flexible routing and door-to-door service capabilities that rail, air, and sea modes cannot replicate for last-mile applications.
The Air Transportation segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the Air Transportation segment is predicted to witness the highest growth rate, driven by the expansion of time-sensitive cold chain freight categories including fresh seafood, exotic produce, cut flowers, and pharmaceutical biologics that require speed of transit to preserve quality and efficacy. The pharmaceutical sector's growing reliance on air freight for cross-border distribution of biologics, clinical trial materials, and specialty medicines is generating premium cold chain air cargo revenues. Temperature-controlled ULD containers and specialized aircraft belly and freighter configurations are improving pharmaceutical cold chain performance.
During the forecast period, the North America region is expected to hold the largest market share, supported by a highly developed refrigerated logistics infrastructure, extensive domestic food distribution networks, and a large pharmaceutical distribution sector with stringent temperature compliance requirements. The United States hosts a dense network of third-party refrigerated logistics operators providing national temperature-controlled distribution for food manufacturers, grocery retailers, and pharmaceutical companies.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, propelled by rapid expansion of organized food retail, growing pharmaceutical distribution networks, and government infrastructure investment programs in China, India, and Southeast Asia. China's cold chain development has accelerated dramatically through both private enterprise investment and government policy support for agricultural supply chain modernization, reducing food waste and improving rural-to-urban distribution efficiency.
Key players in the market
Some of the key players in Cold Chain Transportation Market include Lineage Logistics, Americold Logistics, DHL Supply Chain, UPS Healthcare Logistics, A.P. Moller - Maersk, DB Schenker, CEVA Logistics, C.H. Robinson Worldwide, DSV, Kuehne+Nagel, NewCold, Nichirei Logistics Group, U.S. Cold Storage, VersaCold Logistics Services, and Congebec Logistics.
In March 2026, Lineage Logistics announced the commissioning of its largest automated cold storage facility to date in Rotterdam, Netherlands, featuring AI-driven inventory management, robotic pallet retrieval systems, and an integrated cold chain transportation management platform. The facility serves as a multimodal hub connecting sea container, rail, and road temperature-controlled freight across Northern European distribution networks.
In February 2026, DHL Supply Chain announced the launch of its next-generation LifeConEx pharmaceutical cold chain service, incorporating AI-powered temperature risk prediction and proactive intervention protocols for high-value biologic shipments. The service combines IoT temperature data loggers, machine learning anomaly detection, and a 24/7 global command center to monitor pharmaceutical consignments in real-time throughout their transportation journey.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.